1 Min Read
Sept 6 (Reuters) - Nuvasive Inc
* Nuvasive receives FDA 510(K) clearance for leading EOS innovation Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.